Prospective monocentric study, non-randomized of the detection of sarcopenia in clinical practice in patients with ovarian or endometrial cancer requiring systemic oncological treatment.
main question : Identify the criteria correlated with the presence of sarcopenia (defined by the measurement of the IMS by the CT-X method in L3) among the impedancemetry and the HAS malnutrition criteria.
Data collection will be done at 6 months, 12 months after the date of inclusion.
Patients at least 18 years old
Patient presenting with a diagnosis of cancer of ovarian origin with an indication for chemotherapy
Patient with a diagnosis of endometrial cancer with an indication for chemotherapy
Patient with no diagnosis of other types of cancer in the previous five years
Patient with cancer of ovarian origin not requiring chemotherapy treatment
Patient with endometrial cancer not requiring chemotherapy treatment
Discovery of an intercurrent cancer other than skin or cervix cancers.
Patient wearing a Pace maker
Single group
Sarcopenia diagnostic test
Diagnostic testmeasurement of impedance and physical tests ("hand grip" dynamometer, walking test), SEFI nutritional intake questionnaire
clinical screening for sarcopenia
Identify the criteria correlated with the presence of sarcopenia (defined by the measurement of the IMS by the CT-X method in L3) among the impedancemetry and the HAS malnutrition criteria.
Proposal of a composite score for the detection of sarcopenia usable in clinical routine
Statistical analysis of sarcopenia and undernutrition data
Click on the lead sponsor to view all of their trials.
